New drug could spell the end of chemotherapy

THE successful trial of a new leukaemia drug could herald the end of chemotherapy as the main weapon against the blood cancer, says an Australian specialist.

The results of human trials show the drug ibrutinib could save people with chronic lymphocytic leukaemia (CLL) after the disease develops resistance to chemotherapy.

It gives them a much better chance of survival than the standard treatment, according to a presentation at the annual meeting of the American Society of Clinical Oncology.

More than four in 10 patients on ibrutinib entered remission, compared with four in 100 on the standard treatment, says Dr Con Tam of Melbourne's Peter MacCallum Cancer Centre.

CLL is the most common form of leukaemia in Australia and other Western countries. About 50 per cent of people with the disease never develop serious symptoms and don't need treatment.



Shed full of fun to enjoy at open day

premium_icon Shed full of fun to enjoy at open day

Gladstone Men’s Shed offering something for everyone at its open day on...

Rescue in Pancake Creek

premium_icon Rescue in Pancake Creek

Round Hill VMR teamed up with paramedics to rescue a patient

72 HOURS: things to do in Gladstone this weekend

premium_icon 72 HOURS: things to do in Gladstone this weekend

There’s loads on this weekend, here’s just a few things...